Close

Teva Pharma (TEVA) Receives U.S. Approval of Generic Tribenzor Tabs

Go back to Teva Pharma (TEVA) Receives U.S. Approval of Generic Tribenzor Tabs

Teva Announces Approval of Generic Tribenzor® in the United States

November 7, 2016 9:00 AM EST

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced approval of generic Tribenzor®1(olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the U.S. and is in the final stages of launch preparation. Teva also recently received approval and launched generic Azor®2 (amlodipine and olmesartan medoxomil) tablets in the U.S. These products enhance Tevas antihypertensive portfolio.

Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are a combination of an angiotensin II

receptor blocker, a dihydropyridine calcium channel blocker and a thiazide diuretic indicated for the treatment of hypertension, to lower blood pressure.... More